Renata Huzjan Korunić - Search Results

Year	Number of Results
2020	1
2021	5
2022	3
2023	1
2024	0

1

Ultrasonic Evaluation of Diaphragm in Patients with Systemic Sclerosis.

Ljilja Posavec A, Hrkač S, Tečer J, Huzjan Korunić R, Karanović B, Ježić I, Škopljanac I, Piskač Živković N, Mitrović J. Ljilja Posavec A, et al. Among authors: huzjan korunic r. J Pers Med. 2023 Sep 27;13(10):1441. doi: 10.3390/jpm13101441. J Pers Med. 2023. PMID: 37888052 Free PMC article.

2

Ruxolitinib treatment improves muscle mass in patients with myelofibrosis.

Lucijanic M, Galusic D, Soric E, Sedinic M, Cubela M, Huzjan Korunic R, Pejsa V, Kusec R. Lucijanic M, et al. Among authors: huzjan korunic r. Ann Hematol. 2021 Apr;100(4):1105-1106. doi: 10.1007/s00277-020-04243-8. Epub 2020 Sep 1. Ann Hematol. 2021. PMID: 32870367 No abstract available.

3

Baseline and progressive adipopenia in newly diagnosed patients with diffuse large B-cell lymphoma with unfavorable features are associated with worse clinical outcomes.

Lucijanic M, Huzjan Korunic R, Sedinic M, Kovacevic S, Atic A, Pejsa V, Kusec R. Lucijanic M, et al. Among authors: huzjan korunic r. Leuk Lymphoma. 2022 Jul;63(7):1556-1565. doi: 10.1080/10428194.2022.2034160. Epub 2022 Feb 2. Leuk Lymphoma. 2022. PMID: 35105266

4

Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkin's lymphoma patients.

Lucijanić M, Huzjan Korunić R, Ivić M, Fazlić Džankić A, Jonjić Ž, Mitrović Z, Prka Ž, Piršić M, Jakšić O, Gaćina P, Vlasac Glasnović J, Pejša V. Lucijanić M, et al. Among authors: huzjan korunic r. Wien Klin Wochenschr. 2022 Jan;134(1-2):80-82. doi: 10.1007/s00508-021-01850-x. Epub 2021 Apr 9. Wien Klin Wochenschr. 2022. PMID: 33835267

5

Prognostic impact of psoas muscle index in patients with diffuse large B-cell lymphoma might be dependent on the immunochemotherapy type.

Lucijanić M, Korunić RH, Sedinić M, Kušec R, Pejša V. Lucijanić M, et al. Among authors: korunic rh. Leuk Lymphoma. 2021 Oct;62(10):2535-2538. doi: 10.1080/10428194.2021.1919667. Epub 2021 Apr 28. Leuk Lymphoma. 2021. PMID: 33908324 No abstract available.

6

Perirenal and subcutaneous fat differently affect outcomes in newly diagnosed classical Hodgkin lymphoma patients.

Lucijanic M, Huzjan Korunic R, Ivic M, Fazlic Dzankic A, Kusec R, Pejsa V. Lucijanic M, et al. Among authors: huzjan korunic r. Hematol Oncol. 2021 Oct;39(4):575-579. doi: 10.1002/hon.2887. Epub 2021 May 15. Hematol Oncol. 2021. PMID: 33991435 No abstract available.

7

The Importance of a Multidisciplinary Approach in a Patient with Long-term Multisystemic Manifestations of Unrecognized Hereditary Hemorrhagic Telangiectasia.

Sredoja Tišma VS, Vlašić A, Gulin P, Huzjan Korunić R. Sredoja Tišma VS, et al. Among authors: huzjan korunic r. Acta Dermatovenerol Croat. 2022 Sep;30(2):94-98. Acta Dermatovenerol Croat. 2022. PMID: 36254541

8

More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features.

Lucijanic M, Huzjan Korunic R, Sedinic M, Kusec R, Pejsa V. Lucijanic M, et al. Among authors: huzjan korunic r. Ther Clin Risk Manag. 2021 Sep 24;17:1037-1044. doi: 10.2147/TCRM.S323749. eCollection 2021. Ther Clin Risk Manag. 2021. PMID: 34594106 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year